Uromedica
| Uromedica, Inc. was formed in 1997 to develop minimally invasive medical devices that treat unmet medical needs in the area of urinary incontinence and related disorders. Products (sold under the ACT® and ProACT™ brands) are based on patented adjustable balloon technology. Conditions being treated are post-prostatectomy incontinence in men and stress incontinence in women (after earlier interventions have failed). |
Outside the United States
Any prescribing information contained on this website is intended for customers outside the United States where ACT and ProACT incontinence devices are approved for commercial use.
In the United States
Both ACT and ProACT Devices are currently subject to clinical trials in the United States and not approved for commercial use. These devices are investigational and limited by United States federal law to investigational use.
Contact Uromedica for more information on Adjustable Continence Therapies.
—This page last modified Wednesday February 6, 2008